# DePuy Synthes agrees to acquire Gemtrack technology from MinMaxMedical

DePuy Synthes announced a definitive agreement to acquire selective rights to develop, manufacture and commercialize Gemtrack miniature radiofrequency tracking technology from MinMaxMedical for use across its Joints portfolio, including shoulder, hip and knee, for navigation and robotic applications.

- Type: Acquisition
- Announced: 2018-05-25
- Where: Grenoble, France
- Status: announced
- Products: Gemtrack miniature radiofrequency tracking technology, joint reconstruction implants
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [DePuy Synthes](https://endata.com/companies/21191.md) (acquirer)
- [MinMaxMedical](https://endata.com/companies/32100.md) (target)

## Sources

- [business.sherbrookerecord.com](https://business.sherbrookerecord.com/sherbrookerecord/article/bizwire-2026-5-26-depuy-synthes-announces-agreement-to-acquire-miniature-radiofrequency-tracking-technology-across-its-joint-reconstruction-portfolio), 2018-05-25: "DePuy Synthes today announced a definitive agreement to acquire selective rights to develop, manufacture and commercialize Gemtrack technology across its Joints portfolio"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.